The hybrid protein BTH2 suppresses allergic airway inflammation in a murine model of HDM-specific immunotherapy

Article

Abstract: Background: Allergen-specific immunotherapy (AIT) is the only disease-modifying treatment approach t

Palabras claves:

allergen immunotherapy, Blomia tropicalis, experimental model, peripheral blood mononuclear cell, vaccine candidate

Autores:

Belitardo E.M.M.d.A., Caraballo L., Cruz A.A., de Freitas L.A.R., de Santana M.B.R., Fernandes A.M.S., Ferreira F., Garcés L.F.S., Luis Fabián Salazar Garcés, Neves N.M.A., Pacheco L.G.C., Philip Cooper, Pinheiro C.d.S., Santiago L.F., Silva E.S., Silva R.C., Silveira E.F., Torres R.T., Urrego J.R., Vilas-Bôas D.S., Zakzuk J.

Fuentes:

google

scopus